Regulus Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative ...
Live Science2d
Snow Moon 2025: How to see February's full moon rise with the 'Heart of the Lion' before Valentine's Day
February's full Snow Moon will have a royal companion as it rises alongside Regulus, a star nicknamed "Heart of the Lion", ...
American Association of Individual Investors6d
Why Regulus Therapeutics Inc.’s (RGLS) Stock Is Up 23.00%
Regulus Therapeutics Inc.’s RGLS share price has surged by 23.00%, which has investors questioning if this is right time to ...
Regulus Therapeutics Shares Drop 24% Despite Positive ADPKD Trial Data
Shares of Regulus Therapeutics ( RGLS, Financials) fell 24% to $0.89 as of 12:39 p.m. GMT-5 on Wednesday following the ...
Daily Jang21h
February’s Snow Moon to grace sky with stunning twist next week
Sky gazers are in for a stunning treat of Snow Moon which will rise in the east with an orange glow.This event is going to be ...
Starwatch: October belongs to Pegasus
October belongs to Pegasus and the water constellations, which float through the southern sky after nightfall. Reigning supreme high in the south are the Great Square of Pegasus and, stretching from ...
Regulus Therapeutics Provides Positive Clinical And Regulatory Updates For ADPKD Program
(RTTNews) - Regulus Therapeutics Inc. (RGLS) Wednesday announced positive clinical as well as regulatory updates from its autosomal dominant polycystic kidney disease (ADPKD) program.